These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
443 related articles for article (PubMed ID: 17062641)
1. Tyrosine phosphorylation of p145met mediated by EGFR and Src is required for serum-independent survival of human bladder carcinoma cells. Yamamoto N; Mammadova G; Song RX; Fukami Y; Sato K J Cell Sci; 2006 Nov; 119(Pt 22):4623-33. PubMed ID: 17062641 [TBL] [Abstract][Full Text] [Related]
2. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells. Comoglio PM EXS; 1993; 65():131-65. PubMed ID: 8380735 [TBL] [Abstract][Full Text] [Related]
3. Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation. Li Z; Hosoi Y; Cai K; Tanno Y; Matsumoto Y; Enomoto A; Morita A; Nakagawa K; Miyagawa K Biochem Biophys Res Commun; 2006 Mar; 341(2):363-8. PubMed ID: 16414009 [TBL] [Abstract][Full Text] [Related]
4. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells. Xu H; Washington S; Verderame MF; Manni A Breast Cancer Res Treat; 2008 Nov; 112(2):255-61. PubMed ID: 18097746 [TBL] [Abstract][Full Text] [Related]
6. Lead acetate induces EGFR activation upstream of SFK and PKCalpha linkage to the Ras/Raf-1/ERK signaling. Wang CY; Wang YT; Tzeng DW; Yang JL Toxicol Appl Pharmacol; 2009 Mar; 235(2):244-52. PubMed ID: 19133285 [TBL] [Abstract][Full Text] [Related]
7. SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells. Zhang Q; Thomas SM; Xi S; Smithgall TE; Siegfried JM; Kamens J; Gooding WE; Grandis JR Cancer Res; 2004 Sep; 64(17):6166-73. PubMed ID: 15342401 [TBL] [Abstract][Full Text] [Related]
8. A selective c-met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells. Hov H; Holt RU; Rø TB; Fagerli UM; Hjorth-Hansen H; Baykov V; Christensen JG; Waage A; Sundan A; Børset M Clin Cancer Res; 2004 Oct; 10(19):6686-94. PubMed ID: 15475459 [TBL] [Abstract][Full Text] [Related]
9. Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer. Maulik G; Kijima T; Ma PC; Ghosh SK; Lin J; Shapiro GI; Schaefer E; Tibaldi E; Johnson BE; Salgia R Clin Cancer Res; 2002 Feb; 8(2):620-7. PubMed ID: 11839685 [TBL] [Abstract][Full Text] [Related]
10. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation. Darmoul D; Gratio V; Devaud H; Peiretti F; Laburthe M Mol Cancer Res; 2004 Sep; 2(9):514-22. PubMed ID: 15383630 [TBL] [Abstract][Full Text] [Related]
11. Critical role of extracellular signal-regulated kinase phosphorylation on menadione (vitamin K3) induced growth inhibition. Osada S; Saji S; Osada K Cancer; 2001 Mar; 91(6):1156-65. PubMed ID: 11267961 [TBL] [Abstract][Full Text] [Related]
12. The cell dissociation and motility triggered by scatter factor/hepatocyte growth factor are mediated through the cytoplasmic domain of the c-Met receptor. Komada M; Kitamura N Oncogene; 1993 Sep; 8(9):2381-90. PubMed ID: 7689722 [TBL] [Abstract][Full Text] [Related]
13. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Lee LT; Huang YT; Hwang JJ; Lee PP; Ke FC; Nair MP; Kanadaswam C; Lee MT Anticancer Res; 2002; 22(3):1615-27. PubMed ID: 12168845 [TBL] [Abstract][Full Text] [Related]
14. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Song L; Turkson J; Karras JG; Jove R; Haura EB Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138 [TBL] [Abstract][Full Text] [Related]
15. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma. Rahimi N; Tremblay E; McAdam L; Park M; Schwall R; Elliott B Cell Growth Differ; 1996 Feb; 7(2):263-70. PubMed ID: 8822210 [TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1. Matsushita A; Götze T; Korc M Cancer Res; 2007 Nov; 67(21):10309-16. PubMed ID: 17974973 [TBL] [Abstract][Full Text] [Related]
17. Noncompetitive inhibition of hepatocyte growth factor-dependent Met signaling by a phage-derived peptide. Tam EM; Runyon ST; Santell L; Quan C; Yao X; Kirchhofer D; Skelton NJ; Lazarus RA J Mol Biol; 2009 Jan; 385(1):79-90. PubMed ID: 18973760 [TBL] [Abstract][Full Text] [Related]
18. Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells. Hui AY; Meens JA; Schick C; Organ SL; Qiao H; Tremblay EA; Schaeffer E; Uniyal S; Chan BM; Elliott BE J Cell Biochem; 2009 Aug; 107(6):1168-81. PubMed ID: 19533669 [TBL] [Abstract][Full Text] [Related]
19. Src family kinase inhibitors block amphiregulin-mediated autocrine ErbB signaling in normal human keratinocytes. Kansra S; Stoll SW; Johnson JL; Elder JT Mol Pharmacol; 2005 Apr; 67(4):1145-57. PubMed ID: 15615697 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of protein tyrosine phosphatase activity mediates epidermal growth factor receptor signaling in human airway epithelial cells exposed to Zn2+. Tal TL; Graves LM; Silbajoris R; Bromberg PA; Wu W; Samet JM Toxicol Appl Pharmacol; 2006 Jul; 214(1):16-23. PubMed ID: 16410015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]